Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if INMB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
16 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
83 filers reported a long position in INMB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2M | 706.4K | +2.8% |
| AQR CAPITAL MANAGEMENT LLC | $1.1M | 662.2K | +145% |
| BlackRock, Inc. | $507.9K | 311.6K | -73.9% |
| RAYMOND JAMES FINANCIAL INC | $347.2K | 213K | +4.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $310.3K | 190.2K | -61.6% |
| GOLDMAN SACHS GROUP INC | $301.9K | 185.2K | -20% |
| MILLENNIUM MANAGEMENT LLC | $260.1K | 159.6K | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $258.3K | 158.5K | -18.5% |
| JANE STREET GROUP, LLC | $218.8K | 134.2K | +163.5% |
| UBS Group AG | $180K | 110.4K | -56.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.